Individual and Family Discount Dental Plans, Affordable
Dental Care Starting at $79.95 a Year!
1-888-632-5353 
M-F 8 AM - 9 PM EST 

Find Plans in Your Area
 
ZIP code
 

Find Dentists in Your Area
 
ZIP code
 
Dentist last name
(optional)
 




you are here: DentalPlans.com > Dental Health Articles > HealthnewsDigest.com > FDA Approves Novel Antiretroviral Drug

FDA Approves Novel Antiretroviral Drug
Updated: 8/6/2007 7:07:02 PM
(HealthNewsDigest.com) - The U.S. Food and Drug Administration (FDA) today approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

Maraviroc is approved for use in combination with other antiretroviral drugs for the treatment of adults with CCR5-tropic HIV-1, who have been treated with other HIV medications and who have evidence of elevated levels of HIV in their blood (viral load). Rather than fighting HIV inside white blood cells, maraviroc prevents the virus from entering uninfected cells by blocking the predominant route of entry, the CCR5 co-receptor. CCR5 is a protein on the surface of some types of immune cells. Among patients who have previously received HIV medications, approximately 50 percent to 60 percent have circulating CCR5-tropic HIV-1. “This is an important new product for many HIV-infected patients who have not responded to other treatments and have few options,” said Steven Galson, M.D., M.P.H., director of FDA’s Center for Drug Evaluation and Research.

The product label includes a boxed warning about liver toxicity (hepatoxicity) and a statement in the Warnings/Precautions section about the possibility of heart attacks. The FDA’s approval of maraviroc is based on safety and effectiveness data from two double-blind, placebo-controlled studies. The 1,076 clinical trial participants were selected because they still showed evidence of HIV-1 in their blood, despite treatment with other HIV medications. A blood test for CCR5 tropic HIV-1 was used during clinical trials to identify patients appropriate for treatment with maraviroc.

The safety and effectiveness of maraviroc have not been established in adult and pediatric patients who have never been treated with any other HIV drug. Additionally, the drug has not been tested or studied in pregnant women. The FDA recommends that HIV positive women should not breast feed, whether or not they are on antiretroviral medications.

The most common adverse events reported with maraviroc were cough, fever, upper respiratory tract infections, rash, musculoskeletal symptoms, abdominal pain, and dizziness.

Maraviroc is distributed by New York-based Pfizer Inc.

www.HealthNewsDigest.com




Read Original Article

© 2007 HealthnewsDigest.com

Customer Care - 1-888-632-5353 Toll Free

  
Additional Articles
Global Warming: Our Best Guess is Wrong...
Wheaties Celebrates 85 Years
Plan B® One-Step—New FDA-Approved ...
Keeping Your Home Flea Free
Web Site Security
Considering A Career In Cosmetology
Knowing How To Handle Meat And Poultry
Pesticide Levels in Blood Linked to ...
Probiotics Help Gastric-bypass Patients...
New Roadside Survey Shows Steady in Use...
FDA Issues Draft Guidance for Industry ...
Ten Tips to Help Your Child Prepare for...
Loneliness: Human Nature and the Need ...
Risks of Delaying ACL Reconstruction in...
Doctors Talk Frankly About What and of ...
Regular Moderate Alcohol Intake Has in ...
Is it Heat or Ice On an Injury?
Do I Need a Supplement?
Put America on a Diet
Train Travel - Less Polluting?
Population Growth and Climate Change
CPR Mattress: An Innovation That Can ...
An Herbicide Used To Protect Corn Also ...
Milwaukee VA Hospital Gains New Spinal ...
Ugandan Medical Male Circumcision to ...
Entertaining Made Simple And Delicious ...
Leading Pioneers in Antibiotic-Free New...
Why Toxicology Testing Takes Time to of...
Segments of Carotid Artery Respond to ...
How to Prevent the Recession from You ...
Arthritis: Can the Body’s Own Defense ...
Stress and Depression Worsen Childhood ...
FDA Takes Enforcement Action Against ...
Parent's Guide to Cord Blood Foundation...
Women Cheat Too (that may include your ...
Proper Fit and Use of Walkers and Canes...
Nine Supplements for Osteoarthritis ...
The Eco-Dentistry Association™ a Week ...
The Metabolism Miracle
University of Phoenix Expands Advanced ...

Add to Google MSN HealthnewsDigest.com
 Add HealthnewsDigest.com
 To My Yahoo  Subscribe with Bloglines   Subscribe in NewsGator Online HealthnewsDigest.com
 News Feed

The materials and articles published on DentalPlans.com are for informational purposes only. Although DentalPlans.com strives to be accurate and complete, the information is provided without liability for errors. DentalPlans.com does not warrant the accuracy or completeness of the information, text graphics, links, or other items contained on DentalPlans.com.

DentalPlans.com expressly disclaims liability for errors or omissions in these materials and DentalPlans.com makes no commitment to update the information on DentalPlans.com.

DentalPlans.com expressly disclaims all liability for the use or interpretation by others of information on DentalPlans.com. Decisions based on information contained on DentalPlans.com are the sole responsibility of the visitors, and visitors agree to hold DentalPlans.com and its Affiliates harmless against any claims for damages arising from decisions visitors make on such information.

Nothing on DentalPlans.com constitutes medical advice or other forms of advice. DentalPlans.com assumes no responsibility for material created or published by third parties linked to DentalPlans.com with or without DentalPlans.coms knowledge.

Terms of Use | Privacy PolicySite Map | Newsletter | Info to Go | DP Goes Green | Affiliate Program | Contact Us |

The DENTALPLANS.COM website is administered by DENTALPLANS.COM, INC., a licensed Florida Discount Medical Plan Organization, 8100 S.W. 10th Street Suite #2000, Plantation, FL 33324. Plans and Programs offered by DentalPlans.com are not health insurance policies. Plans and Programs offered by DentalPlans.com provide discounts at certain health care providers for medical services. Plans and Programs offered by DentalPlans.com do not make payments directly to the providers of medical services. The Plan or Program member is obligated to pay for all health care services but will receive a discount from those health care providers who have contracted with the Plan, Program or discount plan organization.

© 1999-2009 DentalPlans.com, Inc. All Rights Reserved. Patents Pending.

BBBOnLine Reliability Seal    HACKER SAFE certified sites prevent over 99% of hacker crime.